IQVIA Holdings Inc. (IQV)
NYSE: IQV · Real-Time Price · USD
188.73
-0.07 (-0.04%)
At close: Aug 28, 2025, 4:00 PM
188.90
+0.17 (0.09%)
After-hours: Aug 28, 2025, 5:18 PM EDT
IQVIA Holdings Revenue
IQVIA Holdings had revenue of $4.02B in the quarter ending June 30, 2025, with 5.32% growth. This brings the company's revenue in the last twelve months to $15.70B, up 3.60% year-over-year. In the year 2024, IQVIA Holdings had annual revenue of $15.41B with 2.81% growth.
Revenue (ttm)
$15.70B
Revenue Growth
+3.60%
P/S Ratio
2.13
Revenue / Employee
$178,409
Employees
88,000
Market Cap
32.08B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 15.41B | 421.00M | 2.81% |
Dec 31, 2023 | 14.98B | 574.00M | 3.98% |
Dec 31, 2022 | 14.41B | 536.00M | 3.86% |
Dec 31, 2021 | 13.87B | 2.52B | 22.14% |
Dec 31, 2020 | 11.36B | 271.00M | 2.44% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
IQV News
- 10 hours ago - IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies - PRNewsWire
- 10 days ago - IQVIA and Veeva Announce Long-term Clinical and Commercial Partnerships and Resolution of All Disputes - Business Wire
- 5 weeks ago - IQVIA: Q2 Earnings Exceeded My Expectations - Seeking Alpha
- 5 weeks ago - IQVIA Holdings Inc. (IQV) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - IQVIA beats quarterly estimates on resilient demand for healthcare analytics - Reuters
- 5 weeks ago - IQVIA Reports Second-Quarter 2025 Results - Business Wire
- 6 weeks ago - IQVIA: Competition Is Creating More Challenges Over The Long Haul - Seeking Alpha
- 2 months ago - IQVIA to Announce Second-Quarter 2025 Results on July 22, 2025 - Business Wire